Moieties in antidiabetic drugs as a target of insulin receptors in association with common neurological disorders.

Guzmán, David Calderón; Olguín, Hugo Juárez; García, Ernestina Hernández; Herrera, Maribel Ortiz; Brizuela, Norma Osnaya

Guzmán, David Calderón; Olguín, Hugo Juárez; García, Ernestina Hernández; Herrera, Maribel Ortiz; Brizuela, Norma Osnaya.

Afiliación

Guzmán DC; Laboratory of Neurochemistry, National Institute of Pediatrics, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, CP 04530, Mexico.
Olguín HJ; Laboratory of Pharmacology, National Institute of Pediatrics, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, CP 04530, Mexico.
García EH; Laboratory of Pharmacology, National Institute of Pediatrics, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, CP 04530, Mexico.
Herrera MO; Laboratory of Experimental Bacteriology, National Institute of Pediatrics, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, CP 04530, Mexico.
Brizuela NO; Laboratory of Neurochemistry, National Institute of Pediatrics, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, CP 04530, Mexico.

Biomed Rep ; 4(4): 395-399, 2016 Apr.

Article en En | MEDLINE | ID: mdl-27073619

Palabras clave

antidiabetic drugs; central nervous system; insulin; neurodegenerative disorders; obesity

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Biomed Rep Año: 2016 Tipo del documento: Article País de afiliación: México Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google